The News
PolyTechnos Funds and Sofinnova Partners co-lead EUR 10 million Series-B financing round in French Varioptic
29/03/2004
PolyTechnos Venture-Partners (Munich, Germany) and Sofinnova Partners (Paris, France) announced today the Series-B funding of French Varioptic S.A.
Located in Lyon, Varioptic develops and manufactures electrically controlled optical liquid lenses for the optical industry. The EUR 10 million round was co-led by PolyTechnos funds and Sofinnova Partners. Varioptic last year received a Series-A financing of EUR 2 million from Sofinnova Partners. Headed by Etienne Paillard, who joined the company in December 2003 as CEO, Varioptic was founded in 2002 by President and CTO Dr. Bruno Berge, a former research scientist at the CNRS (French National Center for Scientific Research) and professor at Ecole Normale Supérieure de Lyon.
The company’s technology is based on extensive research conducted at the Université Joseph Fourier (Grenoble) and the Ecole Normale Supérieure de Lyon. Varioptic were the first to hold international patents on a single-element focusing lens based on immiscible liquids. Conventional focus technologies are based on the principle of moving parts, i.e., of precisely shifting delicate glass elements. The Varioptic approach is to sandwich two liquids, one of them conductive, between transparent panes, attach contacts, and control the shape of the interface between the liquids through voltage, using electro-wetting principles. The production costs for the resulting single-element focusing lens “vLens” are considerably lower than those for comparable conventional lenses. In addition, vLens is significantly more durable, substantially faster in focusing, and needs less power than conventional lenses. Varioptic’s outstanding technology enables manufacturers and module manufacturers to deliver a new generation of products including miniature auto-focus lenses and zooms, especially in camera-enabled cell phones.
Varioptic will use the funding for R&D to further develop its know-how and its innovative products for various applications, in order to maintain its technology leadership. Bruno Berge commented, “We are very pleased to be backed by an investment syndicate of notable venture capital partners like PolyTechnos and Sofinnova Partners. PolyTechnos and Sofinnova Partners are uniquely qualified to support us in many kinds of aspects due to their extensive network and experience in the area of optical auto-focus and zoom lenses.” Etienne Paillard added, ”This is a key milestone for Varioptic. In times when investments in technology companies are done after a lot of consideration, the confidence expressed by PolyTechnos and Sofinnova Partners validates our strategy to deliver innovative products such as our smart optics. We will use the resources to further develop Varioptic globally.” Knut Heitmann, Founding Partner of PolyTechnos and former Managing Director R&D of Leitz (now Leica), Germany, has become a member of Varioptic’s scientific advisory board. Having contributed many patented ideas in the field of electro-optics and especially auto-focus itself, he said, ”Varioptic’s technology opens the door to break-through innovations far beyond multimedia applications!” Dirk Kanngiesser, founder and Managing Partner of PolyTechnos Venture-Partners, has joined Varioptic’s Board of Directors. “We are looking forward to working with the excellent Varioptic team,” he said. “Their clever solution for electrically controllable optical lenses combined with an outstanding management team and a high market demand makes Varioptic a company to keep an eye on.” Alain Rodermann, Partner of Sofinnova Partners added, “One of Varioptic’s strongest assets is exceptionally high quality intellectual property. Sofinnova Partners is pleased to have supported the company since its beginning. Varioptic represents for us the ideal kind of investment in today’s world of IT.” *** About Varioptic Varioptic pioneers in designing and manufacturing electrically controlled optical liquid lenses for optical designers. In order to maintain its technology leadership, Varioptic heavily invests in R&D for the further development of innovative products for various applications. Founded in 2002, Varioptic is located in Lyon (France) and headed by Etienne Paillard, CEO. For more information, please visit http://www.varioptic.com/.
About PolyTechnos Venture-Partners
PolyTechnos Venture-Partners is an independent European venture capital firm focusing on early to expansion stage, technology and life science investments predominantly in German-speaking Europe.
Areas of expertise comprise Information Technology & Communications, Industrial & Engineering, Energy, Drug Development, Diagnostics & MedTech, and the respective interfaces.
PolyTechnos helps companies turn technology into business by providing support in areas such as strategy, business development, and organisation building.
PolyTechnos, located in Munich, Germany, was founded in 1998 and currently advises funds totalling approximately EUR 200 million. For more information, please visit http://www.polytechnos.com/.
About Sofinnova Partners
Founded in Paris in 1972, Sofinnova Partners is one of Europe's leading independent venture capital firms. With EUR 550 million under management, Sofinnova Partners invests in start-ups and early-stage companies in information technology and life sciences. Its investment strategy is based on two principles: Investing early in projects with a high potential; and acting as lead or co-lead investor. Sofinnova's investment team consists of 12 professionals, all recognized experts in their field, who bring valuable market insight and technical expertise to Sofinnova's portfolio companies. Since the firm is increasingly solicited for financing pan-European projects, half of Sofinnova's most recent fund, Sofinnova Capital IV, will be invested outside France.
Contact: Isabelle Jourdain Communication Manager Varioptic S.A. Tel.: +33 (0) 6 87 71 20 95 3, Allée Pierre de Couber
2004
- 21/01/2004
- 21/01/2004
- 28/01/2004
- 26/01/2004
- 26/01/2004
- 29/01/2004
-
29/01/2004
Sofinnova Partners investit dans InfraWorlds, société à fort potentiel
- 09/02/2004
- 09/02/2004
- 16/02/2004
- 25/02/2004
- 25/02/2004
-
26/02/2004
Esmertec gains a worldwide leadership role in fast growing mobile Java™ markets
- 24/02/2004
- 24/02/2004
-
23/02/2004
SOFINNOVA earmarks €85 million to accelerate activity in European wireless market
- 04/03/2004
- 08/03/2004
- 17/03/2004
- 08/03/2004
- 18/03/2004
-
29/03/2004
PolyTechnos Funds and Sofinnova Partners co-lead EUR 10 million Series-B financing round in French Varioptic
- 29/03/2004
-
07/04/2004
Esmertec™ provides Time Warner Cable with JVM solution for the OCAP Market
- 06/04/2004
- 06/04/2004
- 20/04/2004
- 21/04/2004
- 27/04/2004
-
03/05/2004
Vidiom Systems Selects Esmertec™ to provide the JVM solution for its OCAP Products
-
05/05/2004
Georges Haas, Ph.D., Joins Ingenium’s Supervisory Board Munich, Germany, May 5, 2004
-
10/05/2004
Faust raises 16 million euros to further develop its product candidates
-
10/05/2004
Faust Pharmaceuticals lève 16 M d’euros pour développer ses produits en clinique
-
03/05/2004
Saegis Pharmaceuticals Begins Phase II Clinical Trial of SGS742 for Alzheimer’s Disease
- 28/04/2004
-
12/05/2004
Ingenium Acquires Pivotal Patents for INGENOtypingTM Platform
-
17/05/2004
Addex Pharmaceuticals Completes Largest ever European Biotech Series B Fund Raising
- 19/05/2004
- 25/05/2004
- 10/06/2004
- 07/06/2004
- 22/06/2004
- 07/06/2004
- 14/06/2004
-
14/06/2004
TRISENOX® Produces Hematologic Responses in 27 Percent of MDS Patients
-
22/06/2004
Esmertec to demonstrate new breakthrough Java™ Solution – Jbed™ Advanced during JavaOne 2004
- 22/06/2004
-
28/06/2004
Esmertec’s Java™ Virtual Machine (JVM) solution for mobile phones is selected by Panasonic
- 01/07/2004
- 23/06/2004
-
06/07/2004
Atomz Named to Second-Annual AlwaysOnTM List of Top 100 Private Companies
- 30/06/2004
-
12/07/2004
Qosmos reçoit un premier tour de financement de Sofinnova Partners
-
12/07/2004
Qosmos receives a first round of financing from Sofinnova Partners
-
07/07/2004
Esmertec ouvre un centre d'assistance clientèle et de test à Taipei (Taiwan)
-
07/07/2004
Esmertec is opening Customer Support and Testing Centre in Taipei, Taiwan
-
19/07/2004
Ablynx and Procter&Gamble form nanobody drug discovery and development partnership
- 22/07/2004
- 20/07/2004
-
22/07/2004
Esmertec welcomes Michel Bon, Former CEO and Chairman of France Telecom, to its Board
-
26/07/2004
Cell Therapeutics, Inc. Completes Enrollment in Third Pivotal Trial of XYOTAX™ in Lung Cancer
- 26/07/2004
-
28/07/2004
Diatos Elected Among the Top 15 Emerging Biotech Companies of 2004
-
30/07/2004
6WIND emporers customers and partners with a further commitment to quality
-
02/08/2004
Les plus hautes performances Java jamais atteintes sur cœur de MIPS32 24Kc
-
02/08/2004
Highest Java™ Performance Achieved by the MIPS32® 24Kc™ Core
- 27/07/2004
- 27/07/2004
- 16/08/2004
-
09/08/2004
"Euronext n'a pas la place financière qu'il mérite" Jean-Bernard Schmidt - Les Echos 9 Août 2004 -
-
30/08/2004
Tony Reis, l’ancien CEO de Swisscom, rejoint le Conseil d’Administration d’Esmertec
-
30/08/2004
Tony Reis, Former CEO of Swisscom, joins Esmertec’s Board of Directors
-
24/08/2004
Enfora partners with Esmertec to enable wireless Java technology in their GSM/GPRS OEM devices
-
24/08/2004
Enfora se rapproche d’Esmertec pour intégrer la technologie Java dans ses terminaux GSM/GPRS
-
16/08/2004
Intransa secures twenty five million dollars in series D funding
-
06/09/2004
Sensitive Object secures 2 million € Series A financing round from Sofinnova Partners
- 06/09/2004
-
08/09/2004
Oxxius reçoit un premier financement de 2,4 millions d'euros de Sofinnova Partners
-
14/09/2004
Le Dr Ulrich Schumacher rejoint le Conseil d’Administration d’Esmertec
-
08/09/2004
Oxxius receives 2.4 million euros from Sofinnova Partners in first round of financing
-
14/09/2004
Dr. Ulrich Schumacher joins Esmertec as a Member of the Board of Directors
- 20/09/2004
- 23/09/2004
-
23/09/2004
France Telecom selects Esmertec as technology partner for its embedded Java platforms
- 30/09/2004
- 30/09/2004
-
26/10/2004
Esmertec lève CHF 23.5 Millions par le biais d’obligations convertibles
-
26/10/2004
Esmertec raises CHF 23.5 Million from convertible note to fund growth
-
26/10/2004
Intransa annouces IP5500 - The industry's next-generation modular IP san solution for the mid-market
-
10/11/2004
Varioptic Selected Most Innovative Company of the Year for Its Liquid Lenses
-
10/11/2004
Varioptic élue Entreprise Innovante de l’année pour ses lentilles liquides
- 18/11/2004
-
18/11/2004
Esmertec Establishes Strategic Relationship with Mitsui & Co.
- 17/11/2004
-
22/11/2004
Ablynx appoints Edwin Moses as chairman of the board of directors
-
23/11/2004
Sendo choisit la solution Java d’Esmertec’s pour ses téléphones mobiles
-
23/11/2004
Sendo has chosen Esmertec’s Java solution for its mobile phones
- 23/11/2004
- 06/12/2004
-
05/12/2004
TRISENOX® Produces Hematologic Responses in 30 Percent of Patients with Higher-Risk MDS
-
09/12/2004
Esmertec to Integrate Hybrid’s OpenGL ES based Graphics Solutions into its Jbed Solution
-
16/12/2004
Diatos moves its lead drug, DTS-201, toward clinical trials in Europe
- 23/12/2004
- 16/12/2004
- 01/11/2004
-
16/12/2004
Esmertec to further secure mobile Java content with SATSA-based implementation from Gemplus
-
16/12/2004
Esmertec sécurise les contenus des mobiles Java avec l’implémentation SATSA de Gemplus